oral glp 1 in development The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro History of glucagon-like peptide-1 receptor
Description
doi:10.1016/J.AJO.2004.10.022 6

These medications have a low risk of causing low blood sugar when used alone but may increase this risk when combined with insulin or sulfonylureas

The pairing is common in India

News Release

GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes
